Stimulation of OX40 has been shown to increase antigen-specific effector T cell responses and patient-specific memory T cell production for therapeutic immunization strategies in cancer to prolong patient survival (Weinberg et al. 2000; Sadun et al. 2008). Here, TNFRSF4 is linked to cancer.